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ABSTRACT 
 
Recent technological advances within the fields of Abdominal Imaging have revolutionised oncological 
imaging. In the investigation of the solid organs in the upper abdomen, extensive examinations are used 
in order to obtain accurate information. To improve the early detection of –still curable– pathological 
changes, novel methods that are faster, easier and still as highly accurate as the ones currently used, are 
warranted; in that way, the needs for higher efficiency in the modern multidisciplinary environment can 
be met in a cost-effective manner. 
 
The overall purpose of this thesis was to develop and optimise MRI methods for the simplified 
oncological imaging evaluation of two important patient groups: 
a. those with pancreatic cancer, by applying diffusion-weighted (DW) MRI (studies I and II), and 
b. those with colorectal cancer liver metastases (CRLM), by using a novel, manganese-based, 
orally administered MRI contrast agent (CMC-001) (studies III and IV). 
 
In study I, the accuracy of DW MRI was evaluated and compared with a conventional comprehensive 
MRI (MRI-c) protocol in 36 patients with pancreatic lesions (12 malignant and 24 benign) and 39 
without lesions. The results showed that DW MRI has an accuracy that is similarly high to that of MRI-
c for the detection of pancreatic cancer. 
In study II, three different DW MRI techniques (respiratory-triggered, free-breathing, and breath-hold) 
were compared regarding image quality, signal intensity and ADC measurement in 15 patients with 
proven pancreatic cancer. The results showed superiority of the respiratory-triggered technique in both 
analyses for demonstrating pancreatic cancer. 
In study III, the sensitivity of MRI to detect CRLM after ingestion of a full-dose of CMC-001 was 
compared with that of a comprehensive intravenous gadobenate dimeglumine protocol as well as their 
safety profile and patient acceptability were compared in 20 patients suspected of having 1-6 such 
lesions. The results showed that CMC-001 and the intravenous gadobenate dimeglumine had similar 
sensitivities; no safety issues were raised for neither contrast agent but CMC-001 had higher rates of 
gastrointestinal adverse events.  
In study IV, the efficacy of three different doses of the contrast agent CMC-001 (corresponding to ½, 
¼ and ⅛ of the full dose) as well as its safety profile and patient acceptability were evaluated in 32 
healthy volunteers. The results showed that ½ dose of CMC-001 had higher efficiency and still 
acceptable adverse drug reactions/adverse events. 
 
In conclusion of studies I and II, DW MRI is as sensitive as the comprehensive MRI protocol in 
detecting pancreatic cancer and for that, the respiratory-triggering seems the optimal technique. In 
conclusion of studies III and IV, the sensitivity of the full dose of oral CMC-001 is as high as the 
intravenous gadobenate dimeglumine protocol but half-dose of this agent should be preferred due to 
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